Synthesized DNA (Eurofins Genomics KK, Tokyo, Japan) encoding mCCR3 (Accession No.: NM_009914.4) [28 (link),29 (link),30 (link)] and mouse CCR8 (mCCR8; Accession No.: NM_007720.2) [32 (link),33 (link),34 (link)] were subcloned into a pCAG-Ble vector (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan). Chimeric mutants mCCR8 (mCCR3p1-38), mCCR8 (mCCR3p96-111), mCCR8 (mCCR3p176-207), and mCCR8 (mCCR3p269-285) were produced with a RAP [42 (link),43 (link)] and a MAP tag [44 (link),45 (link)] at their C-terminus using a HotStar HiFidelity polymerase kit (Qiagen Inc., Hilden, Germany). Alanine (glycine) substitutions in the mCCR3 N-terminal region were conducted using QuikChange Lightning Site-Directed Mutagenesis Kits (Agilent Technologies Inc., Santa Clara, CA, USA). PCR fragments bearing the desired mutations were inserted into the pCAG-Ble vector (FUJIFILM Wako Pure Chemical Corporation) using an In-Fusion HD Cloning Kit (TaKaRa Bio, Inc., Shiga, Japan).
Free full text: Click here